What $350,000 Insider Sale Signals Mineralys Investors
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
This page collects articles under the FDA Decision tag, highlighting biotech signals, insider moves, and history. Learn how these factors could influence your portfolio.
3 articlesA high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...